Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Centre Hospitalier Universitaire, Amiens
Centre Oscar Lambret
University of California, San Diego
Cedars-Sinai Medical Center
Janssen Research & Development, LLC
Adaptimmune
Celgene
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
Centre Hospitalier Universitaire de Besancon
City of Hope Medical Center
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
HistoSonics, Inc.
Institut Curie
Assistance Publique - Hôpitaux de Paris
Hospices Civils de Lyon
Coherus Oncology, Inc.
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Sahlgrenska University Hospital
National Institutes of Health Clinical Center (CC)
Kazia Therapeutics Limited
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Pfizer
Trishula Therapeutics, Inc.
Institut de Cancérologie de Lorraine
Trishula Therapeutics, Inc.
Sidekick Health
University of Alabama at Birmingham
National Institutes of Health Clinical Center (CC)
Revolution Medicines, Inc.
University of Waterloo
Rigshospitalet, Denmark
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
Marmara University
Barretos Cancer Hospital
Sharp HealthCare
Ultimovacs ASA
Astellas Pharma Inc
Karolinska Institutet
Eli Lilly and Company
Lanzhou University Second Hospital
Herlev and Gentofte Hospital
Emory University
Optimal Health Research
RECORDATI GROUP
GlaxoSmithKline